MTRCX
Price
$19.95
Change
+$0.01 (+0.05%)
Updated
Jul 18 closing price
Net Assets
7.67B
RLBBX
Price
$36.55
Change
-$0.03 (-0.08%)
Updated
Jul 18 closing price
Net Assets
252.16B
Interact to see
Advertisement

MTRCX vs RLBBX

Header iconMTRCX vs RLBBX Comparison
Open Charts MTRCX vs RLBBXBanner chart's image
MFS Total Return C
Price$19.95
Change+$0.01 (+0.05%)
VolumeN/A
Net Assets7.67B
American Funds American Balanced R2
Price$36.55
Change-$0.03 (-0.08%)
VolumeN/A
Net Assets252.16B
MTRCX vs RLBBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MTRCX vs. RLBBX commentary
Jul 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTRCX is a Buy and RLBBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBBX has more cash in the bank: 252B vs. MTRCX (7.67B). MTRCX pays higher dividends than RLBBX: MTRCX (1.55) vs RLBBX (1.17). MTRCX was incepted earlier than RLBBX: MTRCX (31 years) vs RLBBX (23 years). MTRCX (1.47) is less costly to investors than RLBBX (1.32). MTRCX is a more actively managed with annual turnover of: 53.00 vs. RLBBX (44.00). RLBBX has a lower initial minimum investment than MTRCX: RLBBX (250) vs MTRCX (1000). RLBBX annual gain was more profitable for investors over the last year : 6.25 vs. MTRCX (-0.70). RLBBX return over 5 years is better than : 34.69 vs. MTRCX (7.74).
MTRCXRLBBXMTRCX / RLBBX
Total Expense Ratio1.471.32111%
Annual Report Gross Expense Ratio1.471.32111%
Fund Existence31 years23 years-
Gain YTD5.1537.70367%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets7.67B252B3%
Annual Yield % from dividends1.551.17132%
Returns for 1 year-0.706.25-11%
Returns for 3 years11.5133.4534%
Returns for 5 years7.7434.6922%
Returns for 10 years22.0855.4140%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACHV2.750.06
+2.23%
Achieve Life Sciences
LIXT3.780.06
+1.61%
Lixte Biotechnology Holdings
DORM122.401.08
+0.89%
Dorman Products
ALNT39.47N/A
N/A
Allient
SMMT27.63-0.64
-2.26%
Summit Therapeutics